361 Capital’s CyrusOne Inc Common Stock CONE Stock Holding History

361 Capital’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,738	Closed	-$758K	–	366
2017 Q4	$758K	Buy	+12,738	New	+$773K	0.19%	205

Other funds holding CONE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

CIMLRA

CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

361 Capital's CONE Position: Q1 2018 in Review

361 Capital sold out of CyrusOne Inc Common Stock (CONE) in Q1 2018, closing a stake of 12,738 shares — an estimated $758K sold.

361 Capital first reported a position in CONE in Q4 2017 and held it in 1 quarter. The position peaked at $758K in Q4 2017. 351 funds tracked by Wall St. Rank hold CONE as of Q1 2018.

361 Capital reported no remaining CyrusOne Inc Common Stock position as of Q1 2018 after selling out during the quarter.
361 Capital sold 12,738 CyrusOne Inc Common Stock shares in Q1 2018, an estimated $758K.
361 Capital first reported a position in CyrusOne Inc Common Stock in Q4 2017 and held it in 1 quarter.
361 Capital's CyrusOne Inc Common Stock position peaked at $758K in Q4 2017.
351 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.